Strategies for converting allergens into hypoallergenic vaccine candidates
- 1 March 2004
- Vol. 32 (3) , 313-320
- https://doi.org/10.1016/j.ymeth.2003.08.016
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergyJournal of Allergy and Clinical Immunology, 2001
- Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergyJournal of Allergy and Clinical Immunology, 2000
- Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Recombinant allergen fragments as candidate preparations for allergen immunotherapyJournal of Allergy and Clinical Immunology, 1997
- Type I allergic reactions to plant-derived food: A consequence of primary sensitization to pollen allergens*Journal of Allergy and Clinical Immunology, 1996
- Signal transduction by Fc receptors: the Fc&RI caseImmunology Today, 1993
- Diagnosis of Grass Pollen Allergy with Recombinant Timothy Grass (Phleum pratense) Pollen AllergensInternational Archives of Allergy and Immunology, 1992
- Recombinant allergens for immunoblot diagnosis of tree-pollen allergyJournal of Allergy and Clinical Immunology, 1991
- Immunotherapy with partially purified and standardized tree pollen extractsAllergy, 1988
- Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two stepsJournal of Allergy and Clinical Immunology, 1981